Overexpression of thioredoxin‐interacting protein (TXNIP) is associated with reduced insulin sensitivity and β‐cell apoptosis. We have previously shown that W2476 inhibited high glucose‐induced TXNIP expression at both mRNA and protein levels i...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=O117879767
2018년
-
1747-0277
1747-0285
SCI;SCIE;SCOPUS
학술저널
1998-2008 [※수록면이 p5 이하이면, Review, Columns, Editor's Note, Abstract 등일 경우가 있습니다.]
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
Overexpression of thioredoxin‐interacting protein (TXNIP) is associated with reduced insulin sensitivity and β‐cell apoptosis. We have previously shown that W2476 inhibited high glucose‐induced TXNIP expression at both mRNA and protein levels i...
Overexpression of thioredoxin‐interacting protein (TXNIP) is associated with reduced insulin sensitivity and β‐cell apoptosis. We have previously shown that W2476 inhibited high glucose‐induced TXNIP expression at both mRNA and protein levels in INS‐1E cells. In this study, we describe structural modification and optimization of W2476 leading to three more active derivatives, 8d, 8g, and 9h, capable of suppressing TXNIP expression in BG73 and INS‐1E cells, increasing insulin production, and reducing high glucose‐induced apoptosis in INS‐1E cells.
Overexpression of TXNIP is associated with reduced insulin sensitivity and β‐cell apoptosis. Our previous work disclosed that W2476 could inhibit high glucose‐induced TXNIP overexpression at both mRNA and protein levels in INS‐1E cells. Subsequent work on the structural modification and optimization of W2476 led to three more active derivatives, 8d, 8g, and 9h, capable of suppressing TXNIP expression in BG73 and INS‐1E cells, increasing insulin production, and reducing high glucose‐induced apoptosis in INS‐1E cells.
An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors
Blueprints for the rational design of therapeutic mutacin 1140 variants
Preparation and biological evaluation of metronidazole derivatives with monoterpenes and eugenol